Transforming ovarian cancer care by targeting minimal residual disease.
Jazaeri AA, Grisham R, Knisely A, Spranger S, Zamarin D, Hillman RT, Lawson BC, Burns KH, Lee S, Westin SN, Moiso E, Williams MJ, Bardhan NM, Pisanic T, Matulonis U, Weigelt B, Shih I, Konstantinopoulos PA, Gaillard S, Wang L, Aghajanian C, D'Andrea AD, Hammond P, Shah S, Wucherpfennig KW, Lu KH.
Jazaeri AA, et al. Among authors: westin sn.
Med. 2023 Nov 10;4(11):755-760. doi: 10.1016/j.medj.2023.08.004.
Med. 2023.
PMID: 37951209
Free PMC article.